Immix Biopharma Inc.

05/29/2026 | Press release | Distributed by Public on 05/29/2026 15:10

Proxy Results (Form 8-K)

Item 5.07. Submission of Matters to a Vote of Security Holders.

On May 22, 2026, at the 2026 Annual Meeting of stockholders (the "Annual Meeting") of Immix Biopharma, Inc. (the "Company"), the Company's stockholders voted on the following two (2) proposals and votes were cast as described below. These matters are described in more detail in the Definitive Proxy Statement on Schedule 14A filed by the Company with the Securities and Exchange Commission on April 6, 2026.

The final results of voting on each proposal presented at the Annual Meeting are set forth below.

1.

Proposal 1 - Election of Directors Proposal

The stockholders elected each of the individuals listed below to serve as a director of the Company until the next annual meeting of stockholders and until such director's successor is duly elected and qualified. The results of the voting for this proposal were as follows:

For Withheld Broker Non-Votes
Ilya Rachman 35,738,887 121,893 6,445,684
Gabriel Morris 34,353,302 1,507,479 6,445,683
Jason Hsu 35,844,812 15,969 6,445,683
Magda Marquet 35,731,188 129,592 6,445,684
Helen C. Adams 35,677,258 183,522 6,445,684
Carey Ng 35,840,860 19,921 6,445,683
Jane Buchan 35,731,346 129,434 6,445,684
Yekaterina Chudnovsky 35,749,420 111,360 6,445,684
Nancy Chang 35,744,455 116,325 6,445,684
2.

Proposal No. 2 - Ratification of Auditors Proposal

The stockholders ratified the appointment of Crowe LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. The results of the voting for this proposal were as follows:

For Against Abstentions Broker Non-Votes
42,276,496 11,526 18,442 -
Immix Biopharma Inc. published this content on May 29, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on May 29, 2026 at 21:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]